Literature DB >> 32236311

Validation to Brazilian Portuguese of the Self-Care Inventory-revised for adults with type 2 diabetes.

Gabriela H Teló1, Fernando de Quadros Iorra2, Bruna S Velho2, Karen Sparrenberger2, Beatriz D Schaan2.   

Abstract

Objective The aim of this study was to cross-culturally adapt and validate the Brazilian Portuguese version of SCI-R to adults with type 2 diabetes. Materials and methods The SCI-R is a 15-question survey that reflects how well patients with diabetes have adhered to treatment recommendations. A pretest (n = 40) was first performed to improve comprehension of the survey items. A final version was then self-administered in another 75 adults with type 2 diabetes to determine the survey's reliability and validity according to its association with HbA1c. Finally, we conducted a test-retest reliability analysis over three weeks to stabilize the sample and determine intra-observer variability. Results After the pretest phase, the final sample's (N = 75) mean age was 59.9 ± 7.5 years and mean HbA1c level was 8.6 ± 1.5% (70 ± 16.4 mmol/mol). The initial Cronbach's alpha was 0.61; however, further analysis showed that four items had low item correlation and were excluded from the final version, which increased the Cronbach's alpha to 0.63. In predictive validity analysis, HbA1c levels correlated significantly with total survey scores (r = -0.38, P = 0.001). The intra-class correlation coefficient between baseline and three-week scores was 0.93, which indicates high reproducibility. Conclusions The Brazilian Portuguese version of the SCI-R is a valid tool for measuring treatment adherence in adults with type 2 diabetes.

Entities:  

Mesh:

Year:  2020        PMID: 32236311     DOI: 10.20945/2359-3997000000213

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  1 in total

1.  Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial.

Authors:  Janine Alessi; Giovana Berger de Oliveira; Debora Wilke Franco; Alice Scalzilli Becker; Carolina Padilla Knijnik; Gabriel Luiz Kobe; Bibiana Brino Amaral; Ariane de Brito; Beatriz D Schaan; Gabriela Heiden Telo
Journal:  Acta Diabetol       Date:  2021-03-15       Impact factor: 4.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.